What is the management approach for Triple A (Adrenal Insufficiency, Achalasia, Alacrima) syndrome without rupture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Triple A Syndrome (Allgrove Syndrome) Without Rupture

The management of Triple A syndrome requires a multidisciplinary approach addressing all three cardinal manifestations: adrenal insufficiency with glucocorticoid and mineralocorticoid replacement, achalasia with endoscopic or surgical intervention, and alacrima with artificial tears. 1, 2

Adrenal Insufficiency Management

Glucocorticoid Replacement

  • Hydrocortisone is the preferred glucocorticoid replacement:
    • Standard dosage: 10-30 mg daily in divided doses 3
    • Typical regimen: Higher morning dose (⅔ of total) and smaller afternoon dose (⅓ of total)
    • Alternative: Prednisone 5-10 mg daily can be used 3

Mineralocorticoid Replacement

  • Fludrocortisone (standard therapy):
    • Initial dose: 0.1 mg daily 4
    • Dose range: 0.1 mg three times weekly to 0.2 mg daily 4
    • Reduce to 0.05 mg daily if transient hypertension develops 4

Stress Dosing Protocol

  • Minor illness (fever <38°C): Double oral glucocorticoid dose 3
  • Moderate illness (fever >38°C, vomiting, diarrhea): Triple oral dose or use parenteral hydrocortisone 3
  • Severe illness/surgery: 100 mg hydrocortisone IV/IM before procedure, then every 6 hours 3
  • Adrenal crisis: Immediate 100 mg hydrocortisone IV bolus, followed by continuous infusion of 200 mg/24h or 50 mg every 6 hours, plus IV isotonic saline 3

Achalasia Management

Diagnosis

  • High-resolution manometry (HRM) to determine achalasia subtype 5
  • Timed barium esophagram to assess esophageal emptying
  • Endoscopy to rule out pseudoachalasia (malignancy)

Treatment Options

  1. Per-Oral Endoscopic Myotomy (POEM):

    • First-line for Type III achalasia 5
    • Comparable to laparoscopic Heller myotomy for all achalasia subtypes 5
    • Should be performed by experienced physicians in high-volume centers (20-40 procedures needed for competence) 5
    • Post-POEM patients require management for reflux (PPI therapy and/or surveillance endoscopy) 5
  2. Laparoscopic Heller Myotomy (LHM):

    • Highly efficacious for Type I and II achalasia 5
    • Consider for patients with advanced esophageal dilation, sigmoidization, epiphrenic diverticulum, or hiatal hernia 5
  3. Pneumatic Dilation (PD):

    • Effective for Type I and II achalasia with less morbidity and cost than surgery 5
    • May require repeat dilations over time 5

Alacrima Management

  • Artificial tears for regular lubrication
  • Moisture chamber glasses in severe cases
  • Regular ophthalmological follow-up to prevent corneal damage

Neurological Manifestations

  • Regular neurological assessment for early detection of:
    • Autonomic dysfunction (most common neurological manifestation) 2
    • Peripheral neuropathy
    • Amyotrophy
    • Optic atrophy

Follow-Up and Monitoring

  • Regular adrenal function testing, especially in children with AAAS gene mutations 6
  • Endocrine monitoring: Electrolytes, blood pressure, weight
  • Gastrointestinal follow-up: Symptom assessment, nutritional status
  • Ophthalmologic evaluation: Corneal integrity, tear production (Schirmer's test)
  • Neurological assessment: Peripheral nerve function, autonomic function

Patient Education

  • Medical alert bracelet/card identifying adrenal insufficiency 3
  • Education on stress dosing and emergency injectable hydrocortisone use 3
  • Recognition of early warning signs of adrenal crisis: fever, chills, sweats, fatigue, nausea, vomiting, abdominal pain, and hypotension 3

Special Considerations

  • Early genetic testing recommended when alacrima and at least one more symptom are present 6, 7
  • Patients may present with late-onset neurological findings without the classic triad 8
  • Regular follow-up of adrenal function is necessary in all children with AAAS gene mutations to prevent adrenal crisis 6

References

Research

Triple-A syndrome.

Advances in experimental medicine and biology, 2010

Guideline

Adrenal Crisis Management in PAI Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.